BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 14528375)

  • 1. Noncholesterol-lowering effects of statins.
    Pierre-Paul D; Gahtan V
    Vasc Endovascular Surg; 2003; 37(5):301-13. PubMed ID: 14528375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug Insight: statins and stroke.
    Sacco RL; Liao JK
    Nat Clin Pract Cardiovasc Med; 2005 Nov; 2(11):576-84. PubMed ID: 16258569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors renoprotective?
    Campese VM; Nadim MK; Epstein M
    J Am Soc Nephrol; 2005 Mar; 16 Suppl 1():S11-7. PubMed ID: 15938026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [HMG-CoA reductase inhibitors in prevention of cardiovascular diseases: new mechanisms, aspects and trials].
    Wojakowski W; Gmiński J
    Przegl Lek; 2000; 57(5):291-5. PubMed ID: 11057120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [HMG-CoA reductase inhibitors: anti-atherosclerotic effects other than lipid-lowering].
    Fujita R; Matsushima T
    Nihon Rinsho; 1999 Dec; 57(12):2821-5. PubMed ID: 10638219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basic science review: Statin therapy--Part I: The pleiotropic effects of statins in cardiovascular disease.
    Sadowitz B; Maier KG; Gahtan V
    Vasc Endovascular Surg; 2010 May; 44(4):241-51. PubMed ID: 20403949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin therapy for coronary heart disease and its effect on stroke.
    Switzer JA; Hess DC
    Curr Atheroscler Rep; 2006 Jul; 8(4):337-42. PubMed ID: 16822401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of childhood hypercholesterolemia with HMG-CoA reductase inhibitors.
    Duplaga BA
    Ann Pharmacother; 1999 Nov; 33(11):1224-7. PubMed ID: 10573325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pleiotropic effects of statins].
    Palomäki A
    Duodecim; 2004; 120(4):411-8. PubMed ID: 15065459
    [No Abstract]   [Full Text] [Related]  

  • 10. [Anti-atherosclerotic actions of HMG-CoA reductase inhibitors].
    Gmiński J; Wojakowski W
    Przegl Lek; 1997; 54(11):782-7. PubMed ID: 9501689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pleiotropic effects of HMG-CoA reductase inhibitors.
    Werner N; Nickenig G; Laufs U
    Basic Res Cardiol; 2002 Mar; 97(2):105-16. PubMed ID: 12002257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Transplant coronary artery disease--treatment with statins].
    Wolszakiewicz J; Bilińska M
    Pol Merkur Lekarski; 2004 May; 16(95):472-3. PubMed ID: 15518430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinically relevant pleiotropic effects of statins: drug properties or effects of profound cholesterol reduction?
    Comparato C; Altana C; Bellosta S; Baetta R; Paoletti R; Corsini A
    Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):328-43. PubMed ID: 11887430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lowering cholesterol: how low is low enough?].
    Czuriga I; Edes I
    Orv Hetil; 2006 Jul; 147(29):1349-56. PubMed ID: 16941825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pleiotrophic effect of statins (3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors)].
    Igel M; Sudhop T; von Bergmann K
    Arzneimittelforschung; 2003; 53(8):545-53. PubMed ID: 13677244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pleiotropic effects of statins and related pharmacological experimental approaches.
    Alegret M; Silvestre JS
    Methods Find Exp Clin Pharmacol; 2006 Nov; 28(9):627-56. PubMed ID: 17200729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HMG-CoA Reductase inhibitors: an updated review of patents of novel compounds and formulations (2011-2015).
    Oliveira EF; Santos-Martins D; Ribeiro AM; Brás NF; Cerqueira NS; Sousa SF; Ramos MJ; Fernandes PA
    Expert Opin Ther Pat; 2016 Nov; 26(11):1257-1272. PubMed ID: 27537201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy.
    Danesh FR; Kanwar YS
    FASEB J; 2004 May; 18(7):805-15. PubMed ID: 15117885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins.
    Kertland H
    J Obstet Gynaecol Can; 2003 Mar; 25(3):231-4. PubMed ID: 12610676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hyperlipidemia: decreasing lipid values and effects of statins].
    Mathes P
    Z Kardiol; 2002; 91 Suppl 2():25-9. PubMed ID: 12436762
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.